{"meta":{"query_hash":"d75fef24b96f","filters":{"venue":"Journal of Controversies in Biomedical Research"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d75fef24b96f","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Controversies+in+Biomedical+Research"},"results":[{"id":"W2148619961","doi":"10.15586/jcbmr.2015.3","title":"Disparity of outcomes: the limits of modeling amyotrophic lateral sclerosis in murine models and translating results clinically","year":2015,"lang":"en","type":"article","venue":"Journal of Controversies in Biomedical Research","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Amyotrophic lateral sclerosis; SOD1; Clinical trial; Medicine; Disease; Population; Intensive care medicine; Etiology; Drug development; Bioinformatics; Neuroscience; Pathology; Psychology; Biology; Psychiatry; Drug; Environmental health","score_opus":0.3034189456163247,"score_gpt":0.44593882720426664,"score_spread":0.14251988158794193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148619961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707164,0.000762842,0.0005153571,0.027210925,0.00008199909,0.0004061513,0.000017291135,0.0000029501118,0.0002860412],"genre_scores_gemma":[0.9974768,0.001082076,0.0011646537,0.000104894985,0.000111522764,0.000004647583,0.000002076827,0.000016607259,0.000036688267],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9929788,0.0008176246,0.0022526102,0.00025844347,0.0030507506,0.0006417848],"domain_scores_gemma":[0.9940881,0.003349984,0.00038868558,0.00035591438,0.0012675055,0.0005498005],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013805176,0.00016577488,0.0010676626,0.00081879273,0.000048499103,0.00002673427,0.00051560055,0.0002529008,0.000010305027],"category_scores_gemma":[0.015430503,0.00009745229,0.0001925229,0.0009308427,0.0012446824,0.00023729907,0.00024139314,0.0019111395,7.3776897e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12430735,0.0076593957,0.66517204,0.002129995,0.001494716,0.0012827987,0.028492047,0.022416798,0.07931588,0.002363718,0.0021616425,0.06320364],"study_design_scores_gemma":[0.0565367,0.009083348,0.33991927,0.0054116957,0.00010664358,0.000084248764,0.0034009882,0.5724908,0.00022564385,0.01227355,0.0001562427,0.00031086773],"about_ca_topic_score_codex":0.00075063587,"about_ca_topic_score_gemma":0.00006623572,"teacher_disagreement_score":0.550074,"about_ca_system_score_codex":0.00024799784,"about_ca_system_score_gemma":0.0007739669,"threshold_uncertainty_score":0.99286294},"labels":[],"label_agreement":null},{"id":"W2259072436","doi":"10.15586/jcbmr.2015.10","title":"Overview of Marfan Syndrome: knowns and unknowns","year":2015,"lang":"en","type":"article","venue":"Journal of Controversies in Biomedical Research","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Marfan syndrome; Medicine; Disease; Mitral valve prolapse; Medical diagnosis; Intensive care medicine; Bioinformatics; Pathogenesis; Fibrillin; Pathology; Internal medicine; Mitral valve; Biology","score_opus":0.1335543971006092,"score_gpt":0.4502135988238779,"score_spread":0.31665920172326867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259072436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730254,0.022755181,0.0001417357,0.0024633748,0.00011764285,0.0001749663,0.00001223638,9.83054e-7,0.0013085264],"genre_scores_gemma":[0.99563956,0.0037181175,0.00017011516,0.000036236677,0.00008034371,0.000003033938,0.0000036786284,0.000010699201,0.0003382313],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99746144,0.00044161652,0.00041462132,0.00017556772,0.0011275136,0.00037921814],"domain_scores_gemma":[0.9978844,0.00052663387,0.00011554584,0.00020432733,0.0009045474,0.00036453083],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0039051306,0.000093968934,0.00032764062,0.00047963116,0.000030772022,0.000018861661,0.000396995,0.00015663716,0.00006117781],"category_scores_gemma":[0.010112658,0.00007783579,0.00007767259,0.000478945,0.0008614626,0.000009384144,0.0003770056,0.0004372656,0.00000391124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009579134,0.0028163611,0.09827111,0.0010633034,0.0011484689,0.0016913863,0.00203101,0.0000145690765,0.60656416,0.004597872,0.120598584,0.15162404],"study_design_scores_gemma":[0.019423433,0.016707037,0.06591288,0.00076405733,0.0000446297,0.0010141993,0.008253132,0.00024807226,0.016112622,0.0066867503,0.8643422,0.0004909907],"about_ca_topic_score_codex":0.00008575418,"about_ca_topic_score_gemma":0.000059041737,"teacher_disagreement_score":0.7437436,"about_ca_system_score_codex":0.00007750366,"about_ca_system_score_gemma":0.0006815725,"threshold_uncertainty_score":0.99822557},"labels":[],"label_agreement":null},{"id":"W2606523900","doi":"10.15586/jcbmr.2017.18","title":"Recent flaws in Evidence Based Medicine: statin effects in primary prevention and consequences of suspending the treatment.","year":2017,"lang":"en","type":"article","venue":"Journal of Controversies in Biomedical Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Discontinuation; Statin; Medicine; Rosuvastatin; Medical prescription; Intensive care medicine; Disease; Primary prevention; Internal medicine; Pharmacology","score_opus":0.10044384772260126,"score_gpt":0.4432458102614384,"score_spread":0.3428019625388371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606523900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500189,0.017818084,0.000059434093,0.030886853,0.00017400367,0.00075772277,0.0000011734065,0.0000010086721,0.00028285477],"genre_scores_gemma":[0.96426576,0.03521641,0.00020223795,0.00010834546,0.00015360946,0.0000134379325,8.69033e-7,0.00000500644,0.000034292752],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99648714,0.0009677772,0.0006021077,0.00014642623,0.0014877289,0.00030880875],"domain_scores_gemma":[0.99336684,0.0056430832,0.00029210147,0.00030751782,0.00022366134,0.00016678772],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012069513,0.000089349276,0.0006096932,0.0005481985,0.00008828512,0.000023425948,0.0002360084,0.000089899906,0.000040616116],"category_scores_gemma":[0.020059941,0.000049113554,0.00008526229,0.00028559938,0.0014623611,0.00015584873,0.000051691077,0.00054843945,3.8374594e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006600143,0.0008468303,0.17443751,0.0013683839,0.00020835771,0.0021672084,0.001523441,0.0000040578198,0.022779219,0.00043093512,0.00070519955,0.7889287],"study_design_scores_gemma":[0.03288466,0.011919305,0.91771644,0.016827548,0.000093689254,0.00012832633,0.0019857648,0.00033145657,0.003075115,0.0017273449,0.013198017,0.00011233116],"about_ca_topic_score_codex":0.0010964937,"about_ca_topic_score_gemma":0.00024967638,"teacher_disagreement_score":0.7888164,"about_ca_system_score_codex":0.00064241356,"about_ca_system_score_gemma":0.001150116,"threshold_uncertainty_score":0.9881945},"labels":[],"label_agreement":null}]}